S&P 500   3,970.43 (-0.18%)
DOW   32,486.03 (+0.17%)
QQQ   306.06 (-0.87%)
AAPL   156.84 (-0.91%)
MSFT   272.86 (-1.27%)
META   199.76 (-1.52%)
GOOGL   100.36 (-2.05%)
AMZN   97.37 (-0.68%)
TSLA   189.08 (-1.42%)
NVDA   261.91 (-1.28%)
NIO   9.09 (+1.79%)
BABA   95.27 (+10.62%)
AMD   93.70 (-3.01%)
T   18.92 (+0.26%)
F   11.56 (+0.35%)
MU   58.54 (-2.09%)
CGC   1.86 (-1.33%)
GE   92.80 (-0.55%)
DIS   95.14 (-0.50%)
AMC   4.66 (+2.42%)
PFE   40.06 (-0.40%)
PYPL   72.77 (-0.72%)
NFLX   328.48 (+0.25%)
S&P 500   3,970.43 (-0.18%)
DOW   32,486.03 (+0.17%)
QQQ   306.06 (-0.87%)
AAPL   156.84 (-0.91%)
MSFT   272.86 (-1.27%)
META   199.76 (-1.52%)
GOOGL   100.36 (-2.05%)
AMZN   97.37 (-0.68%)
TSLA   189.08 (-1.42%)
NVDA   261.91 (-1.28%)
NIO   9.09 (+1.79%)
BABA   95.27 (+10.62%)
AMD   93.70 (-3.01%)
T   18.92 (+0.26%)
F   11.56 (+0.35%)
MU   58.54 (-2.09%)
CGC   1.86 (-1.33%)
GE   92.80 (-0.55%)
DIS   95.14 (-0.50%)
AMC   4.66 (+2.42%)
PFE   40.06 (-0.40%)
PYPL   72.77 (-0.72%)
NFLX   328.48 (+0.25%)
S&P 500   3,970.43 (-0.18%)
DOW   32,486.03 (+0.17%)
QQQ   306.06 (-0.87%)
AAPL   156.84 (-0.91%)
MSFT   272.86 (-1.27%)
META   199.76 (-1.52%)
GOOGL   100.36 (-2.05%)
AMZN   97.37 (-0.68%)
TSLA   189.08 (-1.42%)
NVDA   261.91 (-1.28%)
NIO   9.09 (+1.79%)
BABA   95.27 (+10.62%)
AMD   93.70 (-3.01%)
T   18.92 (+0.26%)
F   11.56 (+0.35%)
MU   58.54 (-2.09%)
CGC   1.86 (-1.33%)
GE   92.80 (-0.55%)
DIS   95.14 (-0.50%)
AMC   4.66 (+2.42%)
PFE   40.06 (-0.40%)
PYPL   72.77 (-0.72%)
NFLX   328.48 (+0.25%)
S&P 500   3,970.43 (-0.18%)
DOW   32,486.03 (+0.17%)
QQQ   306.06 (-0.87%)
AAPL   156.84 (-0.91%)
MSFT   272.86 (-1.27%)
META   199.76 (-1.52%)
GOOGL   100.36 (-2.05%)
AMZN   97.37 (-0.68%)
TSLA   189.08 (-1.42%)
NVDA   261.91 (-1.28%)
NIO   9.09 (+1.79%)
BABA   95.27 (+10.62%)
AMD   93.70 (-3.01%)
T   18.92 (+0.26%)
F   11.56 (+0.35%)
MU   58.54 (-2.09%)
CGC   1.86 (-1.33%)
GE   92.80 (-0.55%)
DIS   95.14 (-0.50%)
AMC   4.66 (+2.42%)
PFE   40.06 (-0.40%)
PYPL   72.77 (-0.72%)
NFLX   328.48 (+0.25%)
NASDAQ:ARDS

Aridis Pharmaceuticals - ARDS Insider Trading & Ownership

$0.38
-0.01 (-1.28%)
(As of 03/28/2023 11:01 AM ET)
Add
Compare
Today's Range
$0.38
▼
$0.39
50-Day Range
$0.36
▼
$1.30
52-Week Range
$0.35
▼
$2.77
Volume
53,422 shs
Average Volume
1.67 million shs
Market Capitalization
$11.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

Aridis Pharmaceuticals (NASDAQ:ARDS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
0

ARDS Insider Buying and Selling by Quarter

Get ARDS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aridis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Aridis Pharmaceuticals Insider Trades History

Export to Excel
(Data available from 1/1/2013 forward)












ARDS Insider Trading Activity - Frequently Asked Questions

Who is on Aridis Pharmaceuticals's Insider Roster?

The list of insiders at Aridis Pharmaceuticals includes John F. Hamilton, and Vu Truong. Learn more on insiders at ARDS.

What percentage of Aridis Pharmaceuticals stock is owned by insiders?

12.90% of Aridis Pharmaceuticals stock is owned by insiders. Learn more on ARDS's insider holdings.

Which Aridis Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased ARDS shares in the last 24 months: John F. Hamilton ($9,740.00), and Vu Truong ($25,550.00).

How much insider buying is happening at Aridis Pharmaceuticals?

Insiders have purchased a total of 7,000 ARDS shares in the last 24 months for a total of $35,290.00 bought.

This page (NASDAQ:ARDS) was last updated on 3/28/2023 by MarketBeat.com Staff